Cargando…
Development and validation of MRI-based radiomics signatures as new markers for preoperative assessment of EGFR mutation and subtypes from bone metastases
BACKGROUND: This study aimed to develop and externally validate contrast-enhanced (CE) T1-weighted MRI-based radiomics for the identification of epidermal growth factor receptor (EGFR) mutation, exon-19 deletion and exon-21 L858R mutation from MR imaging of spinal bone metastasis from primary lung a...
Autores principales: | Fan, Ying, Dong, Yue, Sun, Xinyan, Wang, Huan, Zhao, Peng, Wang, Hongbo, Jiang, Xiran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375915/ https://www.ncbi.nlm.nih.gov/pubmed/35964032 http://dx.doi.org/10.1186/s12885-022-09985-4 |
Ejemplares similares
-
Radiomic Signatures for Predicting EGFR Mutation Status in Lung Cancer Brain Metastases
por: Zheng, Lie, et al.
Publicado: (2022) -
Development and Validation of an MRI-Based Radiomics Signature for the Preoperative Prediction of Lymph Node Metastasis in Bladder Cancer
por: Wu, Shaoxu, et al.
Publicado: (2018) -
Elaboration of a multimodal MRI-based radiomics signature for the preoperative prediction of the histological subtype in patients with non-small-cell lung cancer
por: Tang, Xing, et al.
Publicado: (2020) -
Radiomics of liver MRI predict metastases in mice
por: Becker, Anton S., et al.
Publicado: (2018) -
PET/MRI Radiomics in Patients With Brain Metastases
por: Lohmann, Philipp, et al.
Publicado: (2020)